Established in 2007, the Cancer Research UK Cambridge Institute was the first major new cancer research centre in the UK for over 50 years.
Our goal is to combine world leading basic cancer biology with key technologies to bear on practical questions of cancer diagnosis, treatment and prevention.
Research in the Institute focuses primarily on Tumour Ecology and Evolution, with investigations across four main areas:
- Basic research into the cellular and molecular biology of cancer.
- Research in molecular imaging, genomics, bioinformatics and computational biology.
- Research focused on specific cancers, which form a link between laboratory and clinic.
- Clinical investigations including experimental medicine clinical trials and, in the longer term, population-based studies in screening and prevention.
The Institute’s state-of-the-art core facilities play a key role in catalysing science, not only within the Institute, but across Cambridge through multiple collaborations. Each facility provides equipment, support and training as well as the capacity to develop bespoke technologies. The core funding provided by Cancer Research UK allows each of our Group Leaders the freedom to expand their programme of work and follow innovative new ideas.
The Cambridge Biomedical Campus is Europe’s largest centre of health science and medical research, and provides unique access to both the clinic and industry. By working in close alignment with the Cancer Research UK Cambridge Centre, researchers within the Institute can gain from clinical trial infrastructure, additional funding streams as well as networking opportunities. In 2013, the Cancer Research UK Cambridge Institute became a department of the University of Cambridge School of Clinical Medicine, strengthening links with researchers across the University.